Drug Patents owned by Chattem Sanofi

1. List of Children's Allegra Allergy drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8933097 CHATTEM SANOFI Fexofenadine suspension formulation
Aug, 2030

(7 years from now)

Drugs and Companies using FEXOFENADINE HYDROCHLORIDE ingredient

Market Authorisation Date: 24 January, 2011

Treatment: NA

Dosage: SUSPENSION;ORAL

More Information on Dosage

2. List of Xyzal Allergy 24hr drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8633194 CHATTEM SANOFI Pharmaceutical composition of piperazine derivatives
Oct, 2027

(4 years from now)

Drugs and Companies using LEVOCETIRIZINE DIHYDROCHLORIDE ingredient

Market Authorisation Date: 31 January, 2017

Treatment: NA

Dosage: SOLUTION;ORAL

How can I launch a generic of XYZAL ALLERGY 24HR before it's patent expiration?
More Information on Dosage

availability in other generic markets.

Click on the highlighted region to filter.

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic